Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
3.400
+0.010 (0.29%)
Jan 7, 2026, 11:13 AM EST - Market open
Genelux Market Cap
Genelux has a market cap or net worth of $127.9 million as of January 7, 2026. Its market cap has increased by 63.77% in one year.
Market Cap
127.90M
Enterprise Value
108.24M
1-Year Change
63.77%
Ranking
Category
Stock Price
$3.40
Market Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $127.90M, a decrease of -9.73%. That is a compound annual growth rate of -3.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 127.53M | -22.25% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 967.33B |
| Johnson & Johnson | 499.57B |
| AbbVie | 405.28B |
| UnitedHealth Group | 304.72B |
| AstraZeneca | 284.35B |
| Novartis AG | 266.00B |
| Merck & Co. | 264.21B |
| Novo Nordisk | 230.76B |